Empagliflozin use is associated with slower progression of chronic kidney disease
1. Empagliflozin led to a lower risk of kidney disease progression in patients with chronic kidney disease (CKD) as compared ...
1. Empagliflozin led to a lower risk of kidney disease progression in patients with chronic kidney disease (CKD) as compared ...
1. In intensive care unit (ICU) patients with delirium, haloperidol treatment did not improve the number of days alive and ...
1. In advanced-stage chronic kidney disease (CKD), there was no significant difference in long-term glomerular filtration rate (eGFR) between those ...
1. Inhaled dual bronchodilator therapy did not reduce respiratory symptom points in tobacco-exposed persons with preserved lung function. 2. Compared ...
1. Frailty status upon admission to intermediate care was a strong predictor of mortality. Evidence Rating Level: 2 (Good) Frailty ...
1. Postoperative atrial fibrillation had a similar risk for associated stroke or transient ischemic attack (TIA) as compared to nonoperative ...
1. There are significant differences between measured and estimated glomerular filtration rate (mGFR and eGFR) at the individual patient level. ...
1. In a study that modeled lifetime earning potentials, adult physicians averaged 25% higher earning potential than their pediatric counterparts. ...
1. There is no difference in overcorrection rate when using slow continuous infusion or rapid intermittent bolus administration of hypertonic ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.